UBASH3A and type 1 diabetes mellitus: Although the exact molecular mechanism associated with this gene mutation in type 1 diabetes is largely unknown, Ge et al. suggested that UBASH3A, as a negative regulator of T-cell function, inhibits its induction of NF-κB signalling, thereby affecting the expression of critical genes involved in autoimmunity, such as IL2 [3].